JP2022037143A5 - - Google Patents

Download PDF

Info

Publication number
JP2022037143A5
JP2022037143A5 JP2021204770A JP2021204770A JP2022037143A5 JP 2022037143 A5 JP2022037143 A5 JP 2022037143A5 JP 2021204770 A JP2021204770 A JP 2021204770A JP 2021204770 A JP2021204770 A JP 2021204770A JP 2022037143 A5 JP2022037143 A5 JP 2022037143A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
crosslinked
alkyl
group
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021204770A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022037143A (ja
Filing date
Publication date
Priority claimed from JP2019220818A external-priority patent/JP2020055850A/ja
Application filed filed Critical
Publication of JP2022037143A publication Critical patent/JP2022037143A/ja
Publication of JP2022037143A5 publication Critical patent/JP2022037143A5/ja
Pending legal-status Critical Current

Links

JP2021204770A 2013-03-15 2021-12-17 終末糖化産物(age)前駆体の捕捉剤 Pending JP2022037143A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361792719P 2013-03-15 2013-03-15
US61/792,719 2013-03-15
JP2019220818A JP2020055850A (ja) 2013-03-15 2019-12-06 終末糖化産物(age)前駆体の捕捉剤

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2019220818A Division JP2020055850A (ja) 2013-03-15 2019-12-06 終末糖化産物(age)前駆体の捕捉剤

Publications (2)

Publication Number Publication Date
JP2022037143A JP2022037143A (ja) 2022-03-08
JP2022037143A5 true JP2022037143A5 (https=) 2022-10-07

Family

ID=50439508

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2016501535A Pending JP2016512830A (ja) 2013-03-15 2014-03-12 終末糖化産物(age)前駆体の捕捉剤
JP2018083623A Pending JP2018135365A (ja) 2013-03-15 2018-04-25 終末糖化産物(age)前駆体の捕捉剤
JP2019220818A Pending JP2020055850A (ja) 2013-03-15 2019-12-06 終末糖化産物(age)前駆体の捕捉剤
JP2021204770A Pending JP2022037143A (ja) 2013-03-15 2021-12-17 終末糖化産物(age)前駆体の捕捉剤

Family Applications Before (3)

Application Number Title Priority Date Filing Date
JP2016501535A Pending JP2016512830A (ja) 2013-03-15 2014-03-12 終末糖化産物(age)前駆体の捕捉剤
JP2018083623A Pending JP2018135365A (ja) 2013-03-15 2018-04-25 終末糖化産物(age)前駆体の捕捉剤
JP2019220818A Pending JP2020055850A (ja) 2013-03-15 2019-12-06 終末糖化産物(age)前駆体の捕捉剤

Country Status (24)

Country Link
US (2) US20160024233A1 (https=)
EP (1) EP2968403A1 (https=)
JP (4) JP2016512830A (https=)
KR (1) KR20150130492A (https=)
CN (1) CN105188718A (https=)
AR (1) AR095593A1 (https=)
AU (2) AU2014235500A1 (https=)
BR (1) BR112015023404A8 (https=)
CA (1) CA2906501A1 (https=)
CL (1) CL2015002624A1 (https=)
CR (1) CR20150545A (https=)
DO (1) DOP2015000221A (https=)
EA (1) EA201591733A1 (https=)
HK (1) HK1220607A1 (https=)
IL (1) IL241406A0 (https=)
MA (1) MA38487A1 (https=)
MX (1) MX2015012843A (https=)
PE (1) PE20151766A1 (https=)
PH (1) PH12015502019A1 (https=)
SG (2) SG10201707590XA (https=)
TN (1) TN2015000390A1 (https=)
TW (1) TW201521744A (https=)
UY (1) UY35441A (https=)
WO (1) WO2014150873A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA41202A (fr) * 2014-12-18 2017-10-24 Genzyme Corp Copolymères polydiallymine réticulé pour le traitement du diabète de type 2
EP3675737A4 (en) * 2017-08-31 2021-02-17 Cytosorbents Corporation REDUCTION OF ADVANCED GLYCATION END PRODUCTS FROM BODY FLUIDS

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985938A (en) * 1997-11-05 1999-11-16 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
AU2002257145B2 (en) * 2001-04-18 2005-06-02 Genzyme Corporation Method for lowering serum glucose
WO2005032563A1 (en) * 2003-09-02 2005-04-14 Genzyme Corporation Method for reducing vascular inflammation
US7385012B2 (en) * 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
US7459502B2 (en) * 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
AU2005214971A1 (en) * 2004-02-17 2005-09-01 Dynamis Therapeutics, Inc. Fructoseamine 3 kinase and the formation of collagen and elastin
FR2883873B1 (fr) * 2005-03-31 2009-07-10 Pharmamens Sarl Inhibiteurs d'age
CN105017481B (zh) * 2010-02-24 2018-10-02 瑞立普萨公司 用作胆汁酸螯合剂的交联聚乙烯胺、聚烯丙胺和乙烯亚胺

Similar Documents

Publication Publication Date Title
JP2022037143A5 (https=)
JP2004526778A5 (https=)
JP2020514300A5 (https=)
JP2010515761A5 (https=)
JP2016520652A5 (https=)
JP2005533531A5 (https=)
US8425887B2 (en) Amide dendrimer compositions
JP2018162284A5 (ja) 複数の被覆された粒子を含む組成物及び医薬製剤
CN111989332A (zh) 作为cdk抑制剂的大环化合物、其制备方法及其在医药上的应用
JP2010507011A5 (https=)
HRP20150446T1 (hr) Konjugati koji imaju degradirajuä†u vezu i polimerni reagensi koji su korisni za pripravu takvih konjugata
CA2444046A1 (en) Use of colesevelam in reducing serum glucose
JP2019512006A5 (https=)
US20150094379A1 (en) Dendrimer Compositions
EP2049014A2 (en) Amine dendrimers
JP2010524882A5 (https=)
US20210236539A1 (en) Method of prophylaxis of zika virus infection
JP2007512322A5 (https=)
JP2010515762A (ja) ポサコナゾール−ポリマー複合体、並びに、ポサコナゾールおよびそのポリマー複合体を使用した治療方法
CN104027816B (zh) 一种可去聚乙二醇化的共装载阿霉素和siRNA载体及其合成方法
JP2009514966A5 (https=)
US20130266533A1 (en) Sulfone polymer compositions
CA2620406A1 (en) Method for removing phosphate and polymer used therefore
US11426426B2 (en) Pharmaceutical composition for preventing or treating inflammatory diseases, containing nitrogen monoxide-sensitive acrylamide-based polymer
JP2025512373A5 (https=)